Región Metropolitana de Santiago
Este organismo compró $13.486.726.006.527 en 34.361 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Glaxosmithkline Chile Farmaceutica Limitada.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $951,1 mil M |
| 2025 | $1,7 B |
| 2024 | $1,8 B |
| 2023 | $1,4 B |
| 2022 | $1,1 B |
| 2021 | $1,2 B |
| 2020 | $1,2 B |
| 2019 | $733,5 mil M |
| 2018 | $526,8 mil M |
| 2017 | $476,6 mil M |
| 2016 | $386,6 mil M |
| 2015 | $399,9 mil M |
| 2014 | $267 mil M |
| 2013 | $274,4 mil M |
| 2012 | $223,1 mil M |
| 2011 | $213,6 mil M |
| 2010 | $190,8 mil M |
| 2009 | $204,7 mil M |
| 2008 | $166,3 mil M |
| 2007 | $196,4 mil M |
| 2006 | $27 mil M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 621-289-SE26 | 16-04-2026 | Tecnika S.A. | Aceptada | $386.139.292 |
| 621-273-SE26 | 16-04-2026 | Ascend Laboratories SpA | Aceptada | $958.968.726 |
| 2268-68-AG26 | 16-04-2026 | Sur Master SpA | Aceptada | $3.998.400 |
| 621-305-SE26 | 16-04-2026 | Reutter Limitada | Aceptada | $173.769.750 |
| 621-158-SE26 | 16-04-2026 | Alpha Pharma SpA | Aceptada | $834.057.358 |
| 621-278-SE26 | 16-04-2026 | Distriphar SpA | Aceptada | $1.549.546.600 |
| 621-294-SE26 | 16-04-2026 | Laboratorio Pasteur S.A. | Aceptada | $1.127.837.970 |
| 621-247-SE26 | 14-04-2026 | Instituto Sanitas S.A. | Aceptada | $952.627.130 |
| 621-303-SE26 | 14-04-2026 | Farmaceutica Santiago dos SpA | Aceptada | $142.214.996 |
| 2268-47-AG26 | 14-04-2026 | Tierra de Afal Capacitaciones y Terapias Limitada | Aceptada | $2.000.000 |
| 621-332-TD26 | 14-04-2026 | Productos Farmoquimicos Roche Limitada | Aceptada | $23.107.896 |
| 621-349-SE26 | 14-04-2026 | Novo Nordisk Farmaceutica Limitada | Aceptada | $229.908.000 |
| 621-283-SE26 | 14-04-2026 | Recetario Magistral Endovenoso S.A. | Aceptada | $526.582.426 |
| 621-268-SE26 | 13-04-2026 | Luxypharm SpA | Aceptada | $2.226.632.514 |
| 621-320-SE26 | 13-04-2026 | Farmaceutica Santiago dos SpA | Aceptada | $104.098.344 |
| 621-1395-SE25 | 13-04-2026 | Libra Chile S.A. | Aceptada | $2.350.250.000 |
| 621-306-SE26 | 13-04-2026 | Aspen Chile S.A. | Aceptada | $141.899.468 |
| 621-416-TD26 | 13-04-2026 | Inversiones C&a Limitada | Aceptada | $460.530.000 |
| 621-236-SE26 | 10-04-2026 | Laboratorio Sanderson S.A. | Aceptada | $175.197.036 |
| 621-260-SE26 | 10-04-2026 | Laboratorio Hospifarma Chile Limitada | Aceptada | $132.937.578 |
| 621-312-SE26 | 10-04-2026 | Ic Global Chile SpA | Aceptada | $276.062.150 |
| 621-333-TD26 | 10-04-2026 | Pharmasan S.A. | Aceptada | $1.768.653.974 |
| 621-342-SE26 | 10-04-2026 | Ascend Laboratories SpA | Aceptada | $207.878.919 |
| 2268-67-AG26 | 10-04-2026 | Servicios de Educación y Desarrollo Pre- Escolar SpA | Aceptada | $3.180.000 |
| 621-404-TD26 | 10-04-2026 | Tecnofarma S.A. | Aceptada | $79.615.180 |
| 621-407-TD26 | 10-04-2026 | Aspen Chile S.A. | Aceptada | $82.708.118 |
| 621-255-SE26 | 10-04-2026 | Recben Xenerics Farmaceutica Limitada | Aceptada | $878.174.590 |
| 621-405-SE26 | 10-04-2026 | Mdc Health SpA | Aceptada | $70.629.808 |
| 621-406-SE26 | 10-04-2026 | Fresenius Kabi Chile Limitada | Aceptada | $690.795.000 |
| 621-402-TD26 | 09-04-2026 | Pharmasan S.A. | Aceptada | $22.770.709.500 |
